MTOR and status epilepticus: Interestingly, rapamycin (an mTOR pathway inhibitor) treatment attenuated proteasome beta5 subunit expression in the electrical post-status epilepticus (SE) rat model, which was associated with a reduced seizure frequency (Broekaart et al., 2017).